|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.46 USD | +0.27% |
|
+2.67% | +59.41% |
| 05-09 | Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024 | |
| 05-08 | Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 | MT |
Phibro Animal Health Corporation provided financial guidance for the year ending June 30, 2023. For the year, the company expects net sales to be in the range of $960 million to $1 billion. Net income to be in the range of $45 million to $49 million.
Diluted EPS to be in the range of $1.11 to $1.21.
| 1st Jan change | Capi. | |
|---|---|---|
| +59.41% | 748M | |
| -13.41% | 77.98B | |
| +10.67% | 8.15B | |
| +23.38% | 3.66B | |
| -3.71% | 1.6B | |
| +12.50% | 1.63B | |
| -21.59% | 1.31B | |
| +2.54% | 1.34B | |
| -9.96% | 1.18B | |
| +2.78% | 1.11B |
PHIBRO ANIMAL HEALTH CORPORATION 
